Laboratory research materials for in vitro use only.

GLP-1 Analog (31-aa)

For laboratory research use only (in vitro). Not for human or animal use.

Price range: $89.99 through $379.99

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$89.99
3-4 units5% off$85.49
5-9 units10% off$80.99
10+ units Best Value15% off$76.49

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

InteracVisaMCCrypto

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence H-Aib-EGTFTSDVSSYLEGQAAKEFIAWLVRGRG with C18 fatty diacid at Lys26
Molecular Weight 4113.58 Da
Molecular Formula C187H291N45O59
CAS Number 910463-68-2
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Approved

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

GLP-1 Analog (31-aa) analytical reference compound. Molecular weight 4113.58 Da.

Specifications

Sequence H-Aib-EGTFTSDVSSYLEGQAAKEFIAWLVRGRG with C18 fatty diacid at Lys26
Molecular Weight 4113.58 Da
Molecular Formula C187H291N45O59
CAS 910463-68-2
Purity >=98% (HPLC)
Format Lyophilized powder
Storage Store at -20C. Reconstituted: 2-8C

For laboratory research use only (in vitro). Not for human or animal use.

Additional information

Size

2mg, 5mg, 10mg, 15mg, 20mg, 30mg

Published Research

4 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

Flint A, Raben A, Astrup A, Holst JJ (1998). Journal of Clinical Investigation. PubMed 9449682

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER)

Marso SP, Daniels GH, Tanaka-Taketomi K, et al. (2016). New England Journal of Medicine. PubMed 27295427

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)

Wilding JPH, Batterham RL, Calanna S, et al. (2021). New England Journal of Medicine. PubMed 33567185

Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). New England Journal of Medicine. PubMed 35658024

For laboratory research use only (in vitro). Not for human or animal use.

Age Verification Required

You must be 19 years of age or older to access this website. This site contains laboratory research materials restricted to qualified personnel.